Monthly News Roundup - July 2018

GnRH Antagonist Orilissa OK ’d for Moderate to Severe Endometriosis Pain Endometriosis is a common gynecologic disorder associated with chronic pelvic pain in women. The FDA has now approved AbbVie’s Orilissa (elagolix), the first oral...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news